# Polyunsaturated Fatty Acid (PUFA) Composition of Growth Medium Changes the Atherogenic Potential of Human Aortic Endothelial Cells (HAECs) Following Endotoxin Stimulation

**Authors:** Nikolina Kolobarić, Zrinka Mihaljević, Mirjana Suver Stević, Ana Marinčić Žagar, Sandor G. Vari, Ines Drenjančević

PMC · DOI: 10.3390/biomedicines13112706 · 2025-11-04

## TL;DR

This study shows that adding certain fatty acids to the growth medium of human aortic cells reduces inflammation and oxidative stress caused by endotoxins.

## Contribution

The study reveals molecule-specific effects of PUFAs on endothelial inflammation, emphasizing the importance of PUFA type and context.

## Key findings

- DHA and ALA significantly reduced ROS production and adhesion molecule expression in HAECs.
- PUFAs reduced pro-inflammatory cytokines like IFNγ, TNFα, and IL-6 in LPS-stimulated HAECs.
- EPA showed antioxidant effects mainly at higher LPS concentrations, while ALA increased IL-1α and endoglin.

## Abstract

Background/Objectives: Endothelial activation by lipopolysaccharides (LPS) contributes to inflammation and the development of cardiovascular disease, making n-3 polyunsaturated fatty acids (PUFAs) potential modulators capable of mitigating endothelial dysfunction. The current study examines the effects of long-chain eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), along with their precursor, α-linolenic acid (ALA), on oxidative stress, adhesion molecule expression, and cytokine milieu in LPS-stimulated human aortic endothelial cells (HAECs). Methods: HAECs (fifth passage) were cultured in control medium under standard conditions: ~37 °C, 5% CO2, ≥80% humidity. Cells were incubated in control basal cell medium or medium supplemented with ALA, EPA, DHA, and their combination (50 µM; n = 5 per group). After 48 h, cells were treated overnight (~16 h) with LPS from E. coli (0.75 and 1 µg/mL). HAECs and supernatants were collected for flow cytometry, Luminex, and ELISA assays. Significance was assessed using two-way analysis of variance ANOVA, followed by post hoc analyses (p < 0.05). Spearman’s correlation analysis was performed between markers, and p-values were adjusted using the Benjamini–Hochberg (BH) correction. Results: PUFA supplementation, particularly with DHA and ALA, significantly reduced intracellular reactive oxygen species (ROS) production and the expression of adhesion molecules (ICAM-1, E-selectin) in HAECs under both basal and LPS-stimulated inflammatory conditions. All PUFAs reduced pro-inflammatory cytokine levels (IFNγ, TNFα, IL-6), while ALA increased IL-1α and endoglin expression, indicating differential immunomodulatory effects. EPA exhibited antioxidant and anti-inflammatory effects primarily at higher LPS concentrations. Correlation analysis demonstrated strong interdependence between oxidative stress, inflammatory markers, and vascular activation, further confirming PUFA-mediated endothelial protection. Conclusions: PUFA supplementation produced molecule-specific effects on endothelial inflammation. DHA and ALA consistently showed anti-inflammatory and antioxidative effects, while EPA’s beneficial effect was more pronounced under inflammatory conditions, emphasising the importance of PUFA type and context in managing vascular inflammation.

## Linked entities

- **Proteins:** ICAM1 (intercellular adhesion molecule 1), Sele (selectin, endothelial cell), engl (endoglin, like)
- **Chemicals:** eicosapentaenoic acid (PubChem CID 5282847), docosahexaenoic acid (PubChem CID 445580), α-linolenic acid (PubChem CID 5280934), IL-6 (PubChem CID 165368475)
- **Diseases:** cardiovascular disease (MONDO:0004995)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, ENG (endoglin) [NCBI Gene 2022] {aka END, HHT1, ORW1}, SELE (selectin E) [NCBI Gene 6401] {aka CD62E, ELAM, ELAM1, ESEL, LECAM2, selectin-e}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** endothelial dysfunction (MESH:D014652), inflammation (MESH:D007249), cardiovascular disease (MESH:D002318)
- **Chemicals:** EPA (MESH:D015118), CO2 (MESH:D002245), LPS (MESH:D008070), DHA (MESH:D004281), PUFA (MESH:D005231), ROS (MESH:D017382), ALA (MESH:D017962), n-3 polyunsaturated fatty acids (MESH:D015525)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HAECs — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_U411)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12650724/full.md

---
Source: https://tomesphere.com/paper/PMC12650724